Other OTC - Delayed Quote USD

Stemtech Corporation (STEK)

0.0570 +0.0035 (+6.54%)
At close: April 24 at 3:58 PM EDT
Loading Chart for STEK
DELL
  • Previous Close 0.0535
  • Open 0.0550
  • Bid --
  • Ask --
  • Day's Range 0.0550 - 0.0613
  • 52 Week Range 0.0221 - 0.1029
  • Volume 145,665
  • Avg. Volume 340,542
  • Market Cap (intraday) 5.955M
  • Beta (5Y Monthly) 1.79
  • PE Ratio (TTM) --
  • EPS (TTM) -0.0600
  • Earnings Date --
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

Stemtech Corporation, a stem cell nutrition company, develops science-based products to help the body maintain healthy stem cell physiology in the Americas, Latin America, and Asia. Its products enhance and support the work of the body's stem cells by releasing more stem cells, helping to circulate them in the blood, and migrate them into tissues, where they can perform their daily function of renewal for optimal health. The company offers its dietary supplements products under the RCM System, stemrelease3, Stemflo MigraStem, OraStem, and D-Fuze brand names; and skincare products under the Cellect One brand name. It serves through independent distributors. Stemtech Corporation is headquartered in Naples, Florida.

www.stemtech.com

--

Full Time Employees

December 31

Fiscal Year Ends

Recent News: STEK

Performance Overview: STEK

Trailing total returns as of 4/24/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

STEK
75.38%
S&P 500
6.33%

1-Year Return

STEK
36.60%
S&P 500
22.70%

3-Year Return

STEK
--
S&P 500
10.38%

5-Year Return

STEK
--
S&P 500
10.38%

Compare To: STEK

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: STEK

Valuation Measures

Annual
As of 4/24/2024
  • Market Cap

    5.96M

  • Enterprise Value

    8.74M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    0.85

  • Price/Book (mrq)

    --

  • Enterprise Value/Revenue

    1.88

  • Enterprise Value/EBITDA

    4.46

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -88.04%

  • Return on Assets (ttm)

    -47.50%

  • Return on Equity (ttm)

    --

  • Revenue (ttm)

    4.64M

  • Net Income Avi to Common (ttm)

    -4.08M

  • Diluted EPS (ttm)

    -0.0600

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    323.63k

  • Total Debt/Equity (mrq)

    --

  • Levered Free Cash Flow (ttm)

    -3.79M

Company Insights: STEK

People Also Watch